PainReform Ltd (PRFX): Fair Value Consensus

Corporate company logo of PainReform Ltd (PRFX)

The price action history of PainReform Ltd. (PRFX) on the GURU.Markets platform, where the indicator stands at 240.47, demonstrates the development trajectory of this long-term pain management systems developer. The business is protected by exclusive patents for the Plex03 platform, despite stringent FDA oversight. Stable management is currently focusing on completing tests, which, combined with the success of PRF-110 and the demand for opioid alternatives, is driving commercial growth.

PainReform Ltd (PRFX) - Consensus Target from 07/04/2022 to 11/11/2026

Analytical breakdowns for PainReform Limited (PRFX)

- share price and expert price forecast:
Quote Chart painreform.com|PRFX - Price Target Chart
- stock exchange capitalization data:
Market Value PainReform Limited|PRFX - Enterprise Value
- book capitalization indicators:
Share Book Value PainReform|PRFX - Company Net Assets|Capitalization to Book Value Ratio painreform.com|PRFX - Aggregate Company Assets
- debt obligations and liquidity statistics:
Aggregate Debt to Equity PainReform Ltd.|PRFX - Long-Term Debt to Capital|Ratio of Short-Term Indebtedness to Capital PainReform Corp|PRFX - Company Aggregate Debts|Debts to Book Capitalization PainReform Limited|PRFX - Company Long-Term Debt|Company Short-Term Loans and Borrowings PainReform|Quick Liquidity Indicator painreform.com
- earnings and valuation multiples indicators:
PRFX - Net Profit|Projected Future Earnings PainReform Ltd.|PRFX - Price to Earnings Ratio|Future Price to Earnings Multiple PainReform Ltd|PRFX - Price/Earnings to Growth Ratio|Company Value to EBITDA PainReform Limited|PRFX - Operating profit before deduction of amortization|Earnings per share for the last four quarters PainReform|PRFX - Net earnings per share (EPS TTM)|Year-over-year earnings per one share growth for the last 12 months painreform.com|PRFX - Earnings growth in current year|Expected net earnings per share growth next year PainReform Ltd.
General company analysis:PRFX painreform.com
Flagship merchandise of PainReform Corp

The consensus forecast dynamics for the market value of PainReform Ltd. (PRFX) reflect market expectations regarding the commercial success of PainReform Ltd. (PRFX) biopolymer developments in the field of local anesthesia. This indicator represents a weighted average of target prices from leading analysts, capturing shifts in investor sentiment as new R&D data emerges, which allows for the prompt adjustment of capital management strategies based on professional valuations.

Competitors of PainReform Ltd.

HLN: Forecast Levels Chart|Price Target Chart Kenvue KVUE|Fair Value Consensus VRNA|Jyong Biotech Corp - Analyst Consensus Forecast|Forecast Levels Chart LGND|AMRX (Amneal Pharmaceuticals) - Consensus Target|Broker Consensus Forecast PRGO|Price Target Chart Alvotech SA|Liquidia Corp - Forecast Levels Chart|Analyst Consensus Forecast GLPG|ANIP (ANI Pharmaceuticals Corp) - Fair Value Consensus|Analyst Consensus Forecast MNKD (MannKind Corporation)|Analyst Consensus Forecast amphastar.com AMPH|PCRX - Price Target Chart|Fair Value Consensus SPRY (ARS Pharmaceuticals Inc)|Theravance (TBPH) - Price Target Chart|Consensus Target Aquestive Corp|SCPH (scPharmaceuticals, Inc.) - Analyst Consensus Forecast|Analyst Consensus Forecast Tectonic|Consensus Target TNXP (Tonix Pharmaceuticals Holding Corp.)|SXTC (sxtchina.com) - Fair Value Consensus|Price Target Chart Eupraxia Pharmaceuticals Inc. EPRX|BioHarvest Sciences Inc (BHST) - Average Forecast Price|EXOZ: Consensus Target|Oramed Pharmaceuticals - Analyst Forecast Prices|ENTX: Analyst Consensus Forecast|MindWalk Holdings, Inc. - Fair Value Consensus|ABVC (ABVC BioPharma Inc) - Analyst Consensus Forecast|Average Forecast Price Cumberland Corp CPIX|Price Target Chart Quantum BioPharma Ltd (QNTM)|FGEN (fibrogen.com) - Fair Value Consensus|Price Target Chart Telomir Pharmaceuticals, Inc. TELO|RANI (Rani Therapeutics Holdings) - Forecast Levels Chart|Synergy CHC Corporation - Analyst Consensus Forecast|RLYB - Analyst Consensus Forecast|LEXX: Analyst Consensus Forecast|PULM - Analyst Median Target|Price Target Chart Pheton Holdings Limited|Broker Consensus Forecast APM (Aptorum)|Price Target Chart Lyra Therapeutics, Inc (LYRA)|IBO (impactbiomedinc.com) - Fair Value Consensus|Analyst Consensus Forecast TNFA (TNF Pharmaceuticals, Inc.)|cbdMD Inc. (YCBD) - Average Forecast Price|Auris Medical - Analyst Consensus Forecast|Forecast Levels Chart LIPO|Optinose (OPTN) - Price Target Chart|Average Forecast Price Pieris Pharma (PIRS)|Price Target Chart Procaps Group S.A.|PTPI: Fair Value Consensus|Price Target Chart Qilian International Holding (QLI)|Consensus Target Acelyrin Inc. SLRN|TFF Pharma - Consensus Target